1 Albuquerque EX, Pereira EF, Alkondon M and Rogers SW: Mammalian nicotinic acetylcholine receptors: From structure to function. Physiol Rev. 89:73–120. 2009. View Article : Google Scholar : PubMed/NCBI

2 Niu XM and Lu S: Acetylcholine receptor pathway in lung cancer: New twists to an old story. World J Clin Oncol. 5:667–676. 2014. View Article : Google Scholar : PubMed/NCBI

3 Schuller HM: Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat Rev Cancer. 9:195–205. 2009. View Article : Google Scholar : PubMed/NCBI

4 Trombino S, Cesario A, Margaritora S, Granone P, Motta G, Falugi C and Russo P: Alpha7-nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells: Role of mitogen-activated protein kinase pathway. Cancer Res. 64:135–145. 2004. View Article : Google Scholar : PubMed/NCBI

5 Arredondo J, Chernyavsky AI, Jolkovsky DL, Pinkerton KE and Grando SA: Receptor-mediated tobacco toxicity: Cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of alpha7 nicotinic receptor in oral keratinocytes. FASEB J. 20:2093–2101. 2006. View Article : Google Scholar : PubMed/NCBI

6 Nakayama H, Numakawa T and Ikeuchi T: Nicotine-induced phosphorylation of Akt through epidermal growth factor receptor and Src in PC12h cells. J Neurochem. 83:1372–1379. 2002. View Article : Google Scholar : PubMed/NCBI

7 Bierut LJ: Nicotine dependence and genetic variation in the nicotinic receptors. Drug Alcohol Depend. 104(Suppl 1): S64–S69. 2009. View Article : Google Scholar : PubMed/NCBI

8 Catassi A, Servent D, Paleari L, Cesario A and Russo P: Multiple roles of nicotine on cell proliferation and inhibition of apoptosis: Implications on lung carcinogenesis. Mutat Res. 659:221–231. 2008. View Article : Google Scholar : PubMed/NCBI

9 Ng MK, Wu J, Chang E, Wang BY, Katzenberg-Clark R, Ishii-Watabe A and Cooke JP: A central role for nicotinic cholinergic regulation of growth factor-induced endothelial cell migration. Arterioscler Thromb Vasc Biol. 27:106–112. 2007. View Article : Google Scholar : PubMed/NCBI

10 Beasley MB, Brambilla E and Travis WD: The 2004 World Health Organization classification of lung tumors. Semin Roentgenol. 40:90–97. 2005. View Article : Google Scholar : PubMed/NCBI

11 Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, Dong Q, Zhang Q, Gu X, Vijayakrishnan J, et al: Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet. 40:616–622. 2008. View Article : Google Scholar : PubMed/NCBI

12 Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, et al: A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature. 452:633–637. 2008. View Article : Google Scholar : PubMed/NCBI

13 Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, Manolescu A, Thorleifsson G, Stefansson H, Ingason A, et al: A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 452:638–642. 2008. View Article : Google Scholar : PubMed/NCBI

14 McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, et al: EPIC Study: Lung cancer susceptibility locus at 5p15.33. Nat Genet. 40:1404–1406. 2008. View Article : Google Scholar : PubMed/NCBI

15 Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, Matakidou A, Qureshi M, Dong Q, Gu X, Chen WV, et al: Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet. 40:1407–1409. 2008. View Article : Google Scholar : PubMed/NCBI

16 Broderick P, Wang Y, Vijayakrishnan J, Matakidou A, Spitz MR, Eisen T, Amos CI and Houlston RS: Deciphering the impact of common genetic variation on lung cancer risk: A genome-wide association study. Cancer Res. 69:6633–6641. 2009. View Article : Google Scholar : PubMed/NCBI

17 Liu P, Vikis HG, Wang D, Lu Y, Wang Y, Schwartz AG, Pinney SM, Yang P, de Andrade M, Petersen GM, et al: Familial aggregation of common sequence variants on 15q24–25.1 in lung cancer. J Natl Cancer Inst. 100:1326–1330. 2008. View Article : Google Scholar : PubMed/NCBI

18 Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, Mirabello L, Jacobs K, Wheeler W, Yeager M, et al: A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet. 85:679–691. 2009. View Article : Google Scholar : PubMed/NCBI

19 Flora AV, Zambrano CA, Gallego X, Miyamoto JH, Johnson KA, Cowan KA, Stitzel JA and Ehringer MA: Functional characterization of SNPs in CHRNA3/B4 intergenic region associated with drug behaviors. Brain Res. 1529:1–15. 2013. View Article : Google Scholar : PubMed/NCBI

20 Paliwal A, Vaissière T, Krais A, Cuenin C, Cros MP, Zaridze D, Moukeria A, Boffetta P, Hainaut P, Brennan P, et al: Aberrant DNA methylation links cancer susceptibility locus 15q25.1 to apoptotic regulation and lung cancer. Cancer Res. 70:2779–2788. 2010. View Article : Google Scholar : PubMed/NCBI

21 Song P, Sekhon HS, Fu XW, Maier M, Jia Y, Duan J, Proskosil BJ, Gravett C, Lindstrom J, Mark GP, et al: Activated cholinergic signaling provides a target in squamous cell lung carcinoma. Cancer Res. 68:4693–4700. 2008. View Article : Google Scholar : PubMed/NCBI

22 Paleari L, Catassi A, Ciarlo M, Cavalieri Z, Bruzzo C, Servent D, Cesario A, Chessa L, Cilli M, Piccardi F, et al: Role of alpha7-nicotinic acetylcholine receptor in human non-small cell lung cancer proliferation. Cell Prolif. 41:936–959. 2008. View Article : Google Scholar : PubMed/NCBI

23 Heusch WL and Maneckjee R: Signalling pathways involved in nicotine regulation of apoptosis of human lung cancer cells. Carcinogenesis. 19:551–556. 1998. View Article : Google Scholar : PubMed/NCBI

24 Medjber K, Freidja ML, Grelet S, Lorenzato M, Maouche K, Nawrocki-Raby B, Birembaut P, Polette M and Tournier JM: Role of nicotinic acetylcholine receptors in cell proliferation and tumour invasion in broncho-pulmonary carcinomas. Lung Cancer. 87:258–264. 2015. View Article : Google Scholar : PubMed/NCBI

25 Li H, Wang S, Takayama K, Harada T, Okamoto I, Iwama E, Fujii A, Ota K, Hidaka N, Kawano Y, et al: Nicotine induces resistance to erlotinib via cross-talk between α 1 nAChR and EGFR in the non-small cell lung cancer xenograft model. Lung Cancer. 88:1–8. 2015. View Article : Google Scholar : PubMed/NCBI

26 Zhao Q, Gu X, Zhang C, Lu Q, Chen H and Xu L: Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC). Cancer Biol Ther. 16:634–643. 2015. View Article : Google Scholar : PubMed/NCBI

27 Chernyavsky AI, Shchepotin IB, Galitovkiy V and Grando SA: Mechanisms of tumor-promoting activities of nicotine in lung cancer: Synergistic effects of cell membrane and mitochondrial nicotinic acetylcholine receptors. BMC Cancer. 15:1522015. View Article : Google Scholar : PubMed/NCBI

28 Xu R, Shang C, Zhao J, Han Y, Liu J, Chen K and Shi W: Activation of M3 muscarinic receptor by acetylcholine promotes non-small cell lung cancer cell proliferation and invasion via EGFR/PI3K/AKT pathway. Tumour Biol. 36:4091–4100. 2015. View Article : Google Scholar : PubMed/NCBI

29 Zhong X, Fan Y, Ritzenthaler JD, Zhang W, Wang K, Zhou Q and Roman J: Novel link between prostaglandin E2 (PGE2) and cholinergic signaling in lung cancer: The role of c-Jun in PGE2-induced α7 nicotinic acetylcholine receptor expression and tumor cell proliferation. Thorac Cancer. 6:488–500. 2015. View Article : Google Scholar : PubMed/NCBI

30 Schaal C, Padmanabhan J and Chellappan S: The role of nAChR and calcium signaling in pancreatic cancer initiation and progression. Cancers (Basel). 7:1447–1471. 2015. View Article : Google Scholar : PubMed/NCBI

31 Al-Wadei MH, Al-Wadei HA and Schuller HM: Effects of chronic nicotine on the autocrine regulation of pancreatic cancer cells and pancreatic duct epithelial cells by stimulatory and inhibitory neurotransmitters. Carcinogenesis. 33:1745–1753. 2012. View Article : Google Scholar : PubMed/NCBI

32 Al-Wadei MH, Al-Wadei HA and Schuller HM: Pancreatic cancer cells and normal pancreatic duct epithelial cells express an autocrine catecholamine loop that is activated by nicotinic acetylcholine receptors α3, α5, and α7. Mol Cancer Res. 10:239–249. 2012. View Article : Google Scholar : PubMed/NCBI

33 Al-Wadei HA, Plummer HK III and Schuller HM: Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid. Carcinogenesis. 30:506–511. 2009. View Article : Google Scholar : PubMed/NCBI

34 Hermann PC, Sancho P, Cañamero M, Martinelli P, Madriles F, Michl P, Gress T, de Pascual R, Gandia L and Guerra C: Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice. Gastroenterology. 147:1119–1133.e4. 2014. View Article : Google Scholar : PubMed/NCBI

35 Bose C, Zhang H, Udupa KB and Chowdhury P: Activation of p-ERK1/2 by nicotine in pancreatic tumor cell line AR42J: Effects on proliferation and secretion. Am J Physiol Gastrointest Liver Physiol. 289:G926–G934. 2005. View Article : Google Scholar : PubMed/NCBI

36 Chowdhury P and Walker A: A cell-based approach to study changes in the pancreas following nicotine exposure in an animal model of injury. Langenbecks Arch Surg. 393:547–555. 2008. View Article : Google Scholar : PubMed/NCBI

37 Schuller HM, Al-Wadei HA and Majidi M: GABA B receptor is a novel drug target for pancreatic cancer. Cancer. 112:767–778. 2008. View Article : Google Scholar : PubMed/NCBI

38 Momi N, Ponnusamy MP, Kaur S, Rachagani S, Kunigal SS, Chellappan S, Ouellette MM and Batra SK: Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through α7nAChR-mediated MUC4 upregulation. Oncogene. 32:1384–1395. 2013. View Article : Google Scholar : PubMed/NCBI

39 Kunigal S, Ponnusamy MP, Momi N, Batra SK and Chellappan SP: Nicotine, IFN-γ and retinoic acid mediated induction of MUC4 in pancreatic cancer requires E2F1 and STAT-1 transcription factors and utilize different signaling cascades. Mol Cancer. 11:242012. View Article : Google Scholar : PubMed/NCBI

40 Chipitsyna G, Gong Q, Anandanadesan R, Alnajar A, Batra SK, Wittel UA, Cullen DM, Akhter MP, Denhardt DT, Yeo CJ, et al: Induction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cells. Int J Cancer. 125:276–285. 2009. View Article : Google Scholar : PubMed/NCBI

41 Lazar M, Sullivan J, Chipitsyna G, Gong Q, Ng CY, Salem AF, Aziz T, Witkiewicz A, Denhardt DT, Yeo CJ, et al: Involvement of osteopontin in the matrix-degrading and proangiogenic changes mediated by nicotine in pancreatic cancer cells. J Gastrointest Surg. 14:1566–1577. 2010. View Article : Google Scholar : PubMed/NCBI

42 Shin VY, Jin HC, Ng EK, Yu J, Leung WK, Cho CH and Sung JJ: Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induce cyclooxygenase-2 activity in human gastric cancer cells: Involvement of nicotinic acetylcholine receptor (nAChR) and beta-adrenergic receptor signaling pathways. Toxicol Appl Pharmacol. 233:254–261. 2008. View Article : Google Scholar : PubMed/NCBI

43 Chen WY, Huang CY, Cheng WL, Hung CS, Huang MT, Tai CJ, Liu YN, Chen CL and Chang YJ: Alpha 7-nicotinic acetylcholine receptor mediates the sensitivity of gastric cancer cells to 5-fluorouracil. Tumour Biol. 36:9537–9544. 2015. View Article : Google Scholar : PubMed/NCBI